Phibro Animal Health Corporation (PAHC)
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
PAHC or BSX: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?
PAHC's 59% YTD surge rides on strong Animal Health momentum, booming vaccines and global gains despite the rising competition.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PAHC or BSX: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript
Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC or BSX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
